Michael Slade, MD

Michael Slade, MD is a doctor specializing in hematologic malignancies, with a focus on multiple myeloma and other plasma cell disorders, as well as cellular therapy. Located at 4921 Parkview Place in St. Louis, Missouri, United States, Dr. Slade's institution offers expertise in disease relapse after cellular therapy, including autologous stem cell transplant and chimeric antigen receptor T-cell treatments. The institution is dedicated to developing new assays for disease monitoring in multiple myeloma. Dr. Slade is affiliated with Washington University School of Medicine and the Barnes-Jewish Hospital Consortium. The medical staff at this institution also provides care at Barnes-Jewish Hospital and St. Louis Children's Hospital. For more information, visit the FPP Intranet or connect with Dr. Slade on LinkedIn. Terms of Use and Privacy Statement are available for reference, and the institution follows a No Surprises Medical Billing policy.